For over 30 years, this FASEB Science Research Conference (SRC) has covered broad topics relating to DNA, RNA, protein methylation, and the role these epigenetic and post-translational modifications have in development, disease, and cancer. The conference brings together scientists studying diverse aspects of the biochemistry, function, and disease relevance of S-adenosyl-L-methionine (SAMe)-dependent methylation to discuss recent research developments and initiate collaborations. This year’s program will provide ample opportunities for students, fellows, and early-career investigators to interact with leaders in the fields of protein, RNA, and DNA methylation.

The main themes of this FASEB conference are: 1) Protein, DNA, and RNA methylation: 2) Methylation and chromatin regulation in the context of development and disease; 3) Small molecule inhibitors of methyltransferases and demethylases and their therapeutic applications.

Organizers: Clare Davies, PhD; Kai Ge, PhD; Brian Strahl, PhD

Since 2007, this FASEB Science Research Conference (SRC) has been the only scientific meeting of its kind dedicated to exploring protein acetylation and deacetylation, from basic to translational research. The meeting has now evolved to converge the interests of researchers in all areas of dynamic protein acylation.

The conference will bring together research scientists and postdoctoral and graduate student trainees who are currently working on acetylation and related areas. This conference is also aimed at newcomers to this field who are interested in incorporating acetylation research into their existing programs. This meeting will be beneficial to clinical investigators and scientists in the pharmaceutical industry, focusing on diseases affected by protein acetylation and developing treatments targeting acetylation enzymes.

Organizers: Yali Dou, PhD; Daniel Panne, PhD; Ed Seto, PhD

Since 1983, this FASEB Science Research Conference on protein kinases and phosphorylation has promoted scientific excellence and serves as a premier platform for the dissemination of cutting-edge, unpublished research findings. Due to its wide scope, diverse speakers, and vibrant and timely scientific discussions, it is one of our most highly attended meetings.

The program will foster collaboration of ideas and stimulate new avenues of research in structural biology, biochemistry, systems biology, chemical biology, and protein engineering. Organizers have developed a lineup of speakers and presentations to deepen our understanding of molecular mechanisms in critical biological processes, leading to the identification of targets for disease diagnosis, prevention, treatments, and cures. By including both methods-focused and biology-focused sessions, we offer trainees a comprehensive understanding of the field and a glimpse into future developments.

Organizers: Donita Brady, PhD; Margaret Stratton, PhD; Vincent Tagliabracci, PhD; Michael Yaffe, MD, PhD

Cancer research is still pushing scientific boundaries and new developments and insights are entering the clinic at increasing pace. Most of the clinical successes come from our understanding of basic processes that govern cancer initiation and progression, including signal transduction. Consequently, we see that especially inhibitors to signaling molecules, in particular kinases, are entering the clinic very rapidly. Therefore, the molecular mechanisms by which signals are received by cells, transduced towards the proper targets and integrated into a biological response are amongst the most-studied areas in modern biology. In this Joint FEBS/EMBO Lecture Course on Spetses, we are bringing together a number of true experts in the field from basic and translational oncology. This course will cover signaling by various pathways (PI3K, WNT, RAS/RAF) but also DNA damage and protein degradation signaling. We will also cover the consequences of pathway deregulation for cellular processes like metabolism and damage repair. Finally, the application or translation of this knowledge into the clinic will be discussed by the speakers.

Registration and abstract submission: April 1, 2024

Organizers: Boudewijn Burgering, with Co-organizer René Medema

For over 20 years, this world-renowned conference has brought together researchers studying all aspects of RNA degradation in both eukaryotic and prokaryotic systems. This year’s meeting is designed to foster interactions between scientists, focusing particularly on new and early-career researchers.

The conference will feature cutting-edge research related to RNA decay, including basic mechanisms of RNA degradation, the role of RNA binding proteins and noncoding RNAs in RNA turnover, and the impact of RNA decay pathways on cell function and physiology.

Organizers: Alicia Bicknell, PhD; Oliver Mühlemann, PhD; Olivia Rissland, PhD

Since 2009, this essential Science Research Conference (SRC) has provided new and exciting insights into NAD+ biology, one of the most rapidly growing fields in biology.

This discipline has substantial medical implications with direct relevance to autoimmune diseases, cancer, neurodegenerative diseases, diabetes, and more. It brings together topical fields of research, including PARP biology, sirtuin biology, NAD+ metabolism, and signaling by NAD metabolites, such as NAADP. With pharmaceutical companies showing great interest in NAD+ biology due to the importance of its regulation in human disease and NAD’s role in aging, there has been growing interest in translational studies.

Organizers: Andreas H. Guse, PhD; Santina Bruzzone, PhD; Xiaolu Cambronne, PhD; Michael O. Hottiger, DVM, PhD

Conference Language: The official conference language will be English.
Area of expertise: biocatalysis and biotransformations.

The biocat congress is part of a biennial conference series established in 2002. It provides an overview of the latest advances in biocatalysis and biotransformations by integrating the know-how of experts and early-career researchers from academia and industry. biocat2024 will cover the following topics:

• AI and computational methods
• Structure function analysis and enzyme engineering
• Enzymatic and whole-cell biotransformations
• Reaction cascades: Electro-, chemo- and photoenzymatic synergies
• Bioprocess engineering, design of smart reactors
• Facing climate change: Sustainability and circular bioeconomy

Organizers: Conventus Congressmanagement & Marketing GmbH

This workshop aims to bring together and help establish an emerging community with the common goal of four dimensional reconstruction of mammalian development. A number of long­standing questions surrounding the early development of mammals have been inaccessible to molecular research due to technical limitations and poor physical accessibility of these processes. How is the body plan established in the early embryo? How is morphogenesis coordinated with lineage specification? The recent revolutions in advanced light microscopy and bioimage informatics have opened up completely new avenues to address these questions and make fundamental advances in our understanding of the developing mammalian embryo

Organizers: an Ellenberg EMBL HEIDELBERG, GERMANY Kate McDole MRC-LMB CAMBRIDGE, UK Isabel Espinosa Medina JANELIA RESEARCH CAMPUS, USA Robert Prevedel EMBL HEIDELBERG, GERMANY Shankar Srinivas UNIVERSITY OF OXFORD, UK